throbber
9568 Biochemistry, Vol. 48, No. 40. 2009
`19. l-ludder, B. N.. Morales, l. G., Stubna. A.. Mitnck, E.. Hcndrich.
`M. l’.. fad Lindahl. P. A. (2007) Electron paramagnetic resonance
`and Mossbauer spectroscopy of intact mitochondria from rcspiring
`Sacrharamyces t‘erevi.riae. J. Biol. Inorg. Chem. /2. l029-I053.
`. Lindahl. F., Morales. .l. (1. Miao. R.. and Holmes-Hampton. G.
`(2009)
`Isolation of .5'at‘(‘hI1I0n1_yt*¢'.s certviriae mitochondria for
`Mnssbaucr, EPR. and electronic absorption spectroscopic analyses.
`Method: Enzymol. 456. 267-285.
`. Schilkc, B.. Vols-inc. C.. Eeinert, H..and Craig. E. (1999) Evidence for
`a conserved system for iron metabolism in the mitochondria of
`Sacrharnmyces cerevisine. Proc. Natl. Acad. Sri. U.S.A. 96. lD20fr
`l02ll.
`. Kohll-«aw. G. B. (1988) lsopropylmalatc dehydratase from yeast.
`Method: Enzymal. 166, 423429.
`. Munujox. F., Collcanti..l.. Gonzalezsastre. F., and Gella. FJ. (1993)
`Assay of suocinatc—dehydrogenase activity by a v;olorimctric-contin-
`Lrous method using iodonitrotetrnzolium chloride as electron-accep
`tor. Anal. Biochem. 212. 506-509.
`. Tamarit, .l., lrazusta, V.. Morcno—Ccrrneno, A... and Ros, J. (2006)
`Colorimetric assay for the qunrttitation of iron in yeast. Anal.
`Biurhem. J51. l49- l5l.
`. Poiurkova, A. V., and Rehr. .l. 1. (I999) Multiple-scattering x-ray-
`absorption fine-structure Debyevwaller factor calculations. Phys.
`Rev. 859,948 957.
`. Plattner. H., and Schatz, G. U969) Promitochondria ofanaerohicully
`grown yeast. 3. Morphology. Bioz'hen:i:tr_v8. 339 343.
`. Kwnst. K. E., Lai. L. C.. Menda. N., James. D. T.. Aref, 5., and
`Burke, P. V. (2002) Genorrricanalyses of anaerobically induced genes
`in Sarcharanr)'ce.!
`cmrvisiae: Functional
`roles of Rex!
`and
`other factors in mediating the anoztic response. J. Baclelial.
`I84.
`250-265.
`. Paltauf, F., and Sclratz. G. (1969) Promilochondria ofanaerobically
`grown yeast. 2. Lipid composition. Bt'ot'hemirIr_v 8, 33$339.
`. Rosenfcld. E., and Beauvoit. B. (2003) Role of the non-respiratory
`pathways in the utilization of molecular oxygen by Sm'rharam)'¢'e.:
`rerevisiae. Year! 20. lll$—l I44.
`. Barres. M. H., Nobrega, F. 0.. and Tzagolofl. A. (2002) Mitochon-
`drial ferredoxiri is required for heme A synthesis in Sot'chammyre.t
`rerevixiae. J. Biol. Chem 277. 9997-10002.
`. Bultcnu, A. L.. Dancis. A.. Gnreil. M., Montague, l. .l.. Camadra.
`.l. M., and Lesuisse. E. (2007) Oxidative stress and protease dysfunc-
`tion in the yeast model of Friedrcich ataxia. Free Radical Biol. Merl.
`42. I561 l570.
`. l-lassett, R. F., Romeo, A. M., and Kosman, D. J. (1998) Regulation
`of high affinity iron uptake in the yeast Sacrharnmycer rer:w'.riue—
`Role of dioxygen and Fe(ll). .1. Biol. Chem. 273, 7628-7636.
`
`_
`
`. Jensen. L. T.. and Culuttu. V. C. (2002) Regulation ofsarcharamyces
`t-ereviiriue FET4 by oxygen and iron. J. Mal. Biol. 318. 25!-260.
`. waters. B. M., and Eide. D. l. (2002) Combinatorial control ofyeast
`FET4 gene expression by iron, zinc. and oxygen. .1. Biol. Chem. 277.
`33749-33757.
`. Cavaclini. P.. Biasiotto, (3.. Poll. M.. Levi. S.. Verardi. R., Lanella. l.,
`Derosas. M..lngrassit1. R.. Corrado. M., and Arosio, P. (2007) RNA
`silencing of the mitochondrial ABCE7 transporter in HeLa cells
`causes an iron-deficient phenotype with mitochondrial iron overload.
`Blood 109. 3552-3559.
`. Halliwell, B. (2009) The wanderings of a free radical. Free Radical
`Biol. Med. 46. 531-542.
`. lmlay. J. A.
`(2006) lron-sulphur clusters and the problem with
`oxygen. Mal. Microbial. 59. 1073-1082.
`.MlihlenhotT. U.. Richhardt. N.. Gerber. L and Lill, R.
`(2002)
`Characterization of iron-sulfur protein assembly in isolated mito-
`chondria-A requirement for ATP. NADH, and reduced iron. J. Biol.
`Chem. 277, 29810-29816.
`. Rnuen, U.,Springer. A.. Weisheit. D.. Petrat. F., Korth. H. G.. deG:-oat.
`H.. and Sustrnann. R. (2007) Assessment of chelauahle mitochondrial
`iron by using mitochondrion-selective fluorescent iron indicators with
`dilferent iron-binding allinities. ChemBiaChem 8, 341-352.
`.Cambridgc
`Structural Database
`(http://www.ccdc.cam.ac.uk/
`products/csd/).
`.Wilkinson. E. C.. Dung. Y. H., and Que. L.
`(1994) Modeling
`hydrolysis at dinucleat iron centers. J. Am. Chem. Soc. 116. 8394-
`8395.
`.Lange,
`I-l.. Kispal. (i.. and Lill, R.
`(1999) Mechanism of iron
`transport to the site of heme synthesis inside yeast mitochondria.
`J. Biol. Chem. 274. i898‘)-H9996.
`. Lill, P... and Miihlenhoft‘. U. (2006) Iron-sulfur protein biogcncsis in
`eukaryotes: Components and mechanisms. Annu. Rev. Cell. Dev. Biol.
`22, 457-486.
`. Schueck. N. D., Woontner, M., and Koeller. D. M. (200l)The role of
`the mitochondrlon in cellular iron homeostasis. Milnchondriari 1,
`51-60.
`. Burke, M. A., and Ardehali. H. (2007) Mitochondrial ATP-binding
`cassette proteins. Trurtvl. Res. [50, 73-80.
`. Chen. S.. Sanchcz—l-‘crnandez. R.. Lyver, E. R.. Dancis, A., and Rea,
`P. A. (2007) Functional chut‘actcrization ofAtATM 1, AtATMZ, and
`AtATM3, a subfamily of Arabidopsis half-molecule ATP-binding
`cassette transporters implicated in iron homeostasis. J. Biol. Chem.
`282, 21561-21571.
`.Liu. W. T.. and Thorp. H. H. (1993) Bond valence sum analysis
`of metal-ligand bond lengths in mctallocnzyrrtes and model com-
`plexes 2. Refined distances and other enzymes. Irmrg. Chem. 32.
`4102-4105.
`
`Biochemistry 2009, 48, 9569-9581
`DOI:
`l0.l02l/bi90ll82w
`
`9569
`
`The Yeast Iron Regulatory Proteins Grx3/4 and Fra2 Form Heterodimeric Complexes
`Containing a [2Fe-2S] Cluster with Cysteinyl and Histidyl Ligationl
`
`Haoran Li,‘ Daphne T. Mapolelofl Nin N. Dingrafxsunil G. Naik," Nicholas S. Lees} Brian M. Hoffman,‘
`Pamela J. Riggs-Gelascof’ Boi Hanh Huynh,' Michael K. Johnson,” and Caryn E. Outten*'*
`‘Department ofChemistry and Biochemistry, Univerrily o/South Carolina. Columbia, South Carolina 29208,
`°Department of Chemistry and Cemerfar Melalloerzzyme Studies, University of Georgia, Athens, Georgia 30602. Department of
`Physics, Emory University, Atlanta, Georgia 30322, ‘Chemistry Department, Northwestern University, Evanston. 1ll1'n0Is60208.am1
`Departmerrt of Chemistry and Biochemistry, College of Charleston. Charleston, Soul/1 Carolina 29424
`Received July 10, 2009: Revised Manuscript Received A ugust 28, 2009
`
`ABSTRACT: The transcription of iron uptake and storage genes in Sacrharomycer cerevisiae is primarily
`regulated by the transcription factor Aftl. Nuclcocytoplasmic shuttling oi‘ Aftl
`is dependent upon
`mitochondrial Fe-S cluster biosymhesis via a signaling pathway that includes the cytosolic monothiol
`glutaredoxins (Grx3 and Grx4) and the BolA homologue Fra2. However, the interactions between these
`proteins and the iron—dependent mechanism by which they control Aftl
`localization are unclear. To
`reconstitute and characterize components of this signaling pathway in vitro, we have overexpressed yeast
`Fra2 and Grx3/4 in Escherichia ca/i. We have shown that coexpression of recombinant Fra2 with Grx3 or
`Grx4 allows purification of a stable [2Fe-2S]“ cluster-containing Fra2-Grx3 or Fra2—Grx4 heterodimerlc
`complex. Reconstitution of a [2Fe~2S] cluster on Grx3 or Grx4 without Fra2 produces a [2Fe—2S]-bridged
`homodimer. UV~—visible absorption and CD, resonance Raman. EPR, ENDOR, Méissbnuer, and EXAFS
`studies of [2Fe-ZS] Grx3/4 homodimers and the [2Fe-2S] Fra2—Grx3/4 heterodimers indicate that inclusion of
`Fra2 in the Grx3/4 Fe-S complex causes a change in the cluster stability and coordination environment.
`Taken together. our analytical, spectroscopic, and mutagenesis data indicate that Grx3/4 and Fra2 form a Fc-
`S-bridged heterodimeric complex with Fe ligands provided by the active site cysteine ofGrx3/4, glutathione,
`and a histidine residue. Overall, these results suggest that the ability ofthe Fra2-Grx3/4 complex to assemble a
`[2Fe-2S] cluster may act as a signal to control the iron regulon in response to cellular iron status in yeast.
`
`Maintenance of optimal iron levels inside the cell is critical for
`all eukaryotes and most prokaryotes, for iron is both essential
`and potentially toxic. As a protein cofactor, iron can bind directly
`to amino acids, forming mono- or dinuclear iron centers, or it can
`be incorporated with porphyrins or sulfide to form hcmc or Fe-S
`clusters, respectively. However, uncontrolled iron redox chem-
`istry can lead to formation of reactive oxygen species, causing
`extensive cellular and molecular damage that eventually leads to
`cell death (1). Therefore, cells must be able to sense iron levels and
`regulate iron homeostasis accordingly to maintain critical, non-
`toxic levels of this key nutrient.
`The expression of iron uptake and storage genes in the model
`eukaryote Saccharomyces cerevisiae is primarily controlled by the
`Fe-responsive transcription factor Aftl. Aftl is located in the
`cytosol under iron-replete conditions and moves to the nucleus
`
`llliis work was supported by the NIH (ESl3780. C.E.0.: GM62524.
`M.K.J,; GM47295, B.H.l-l.; HLl353l, B.M.H.; P20 RR0l646l, P..l.R.
`-G.) and by the Camille and Henry Drcyfus Foundation (Henry Dreyfus
`Teacher-Scholar Award to P.J.R.-G.). Both the National Synchrotron
`
`under iron—depleted conditions, where it activates genes involved
`in high-affinity ionic iron uptake. sidcrophore iron uptake. and
`vacuolar
`iron transport, known collectively as
`the iron
`regulon (2-7). Nuclcocytoplasmic shuttling of Aftl in yeast is
`regulated by mltocliondrial Fe-S cluster biosynthesis via a
`signaling pathway that includes the cytosolic monothiol glutar-
`edoxins (Grx3' and Grx4),
`the BolA homologue Fra2 (Fe
`repressor of activation-2), and the aminopeptidase P-like protein
`Fral (Fe repressor of activation-l) (8-1 1). When Fe-S cluster
`biosynthesis is active (i.e., under Fe replete conditions),
`this
`signaling pathway is proposed to induce multimerization ofAftl
`in an unknown manner to promote its export from the nu-
`cleus (12). A MCXCZ” motifis required for Aftl trtmslocation in
`response to iron. but the specific function of these residues is
`unclear (2, I l, 12). Under low iron conditions or upon disruption
`of mitochondrial Fe-S cluster biogenesis, the Fral/Fra2/Grx3/
`Grx4 pathway is shut offl allowing Aftl to accumulate in the
`nucleus and activate iron uptake systems. Despite the identifica-
`tion of multiple components in this signaling pathway,
`the
`
`

`
`9570 Biochemistry, Val. 48, Na. 40, 2009
`specific mechanism of iron—dependent regulation of Aftl locali-
`nation by Fral and Grx3/4 is a key gap in our understanding of
`intracellular iron metabolism.
`Yeast Grx3 and Grx4 are members of the monothiol glutar-
`edoxin (Grx) family, which is found in organisms ranging from
`bacteria to humans. Grid and Grx4 are highly homologous
`proteins that possess both an N-terminal thioredoxin~ (Trx-) like
`domain and a C—terminal Grx-like domain (13). Cytosolic Grit}
`and Grx4 perform redundant functions since deletion of each
`gene singly has little effect on iron regulation, while a grx3A
`gr.r4A double mutant exhibits constitutive expression of iron
`regulon genes (9, 10). The putative active site in the Grx~like
`domain of Grx3/4 has a highly conserved CGFS motif that is
`specifically required for interaction with M1! and regulation ofits
`activity (9). A third CGFS-type monothiol Grx in yeast (Grx5) is
`localized to mitochondria where it plays an essential but
`ill—defined role in mitochondrial Fe-S cluster biogenesis (14, 15).
`The human homologue of the yeast cytosolic monothiol Grxs
`(hGrx3, also known as PICOT for PKC—interacting cousin of
`Trx) was initially identified in T lymphocytes where it acts as a
`negative regulator of protein kinase C-9 via an unknown mechan-
`ism (I6). More recently, mammalian Grx3 was shown to inhibit
`cardiomyocyte hypertrophy (i.e.. thickening of the heart muscle)
`by binding to the muscle LEM protein (ML?) and blocking the
`stress-responsive. prohypertrophic calcineurin-nuclear factor of
`the activated T-txll (NFAT) signaling pathway (17).
`Grxs are part of the Trx~fold superfamily and typically
`catalyze thiol-disulfide exchange reactions via monothiol or
`dithiol mechanisms ( 18). The dithiol mechanism requires two Cys
`in the active site (usually in a CPYC motif), with the N-terrninal
`Cys forming a mixed disulfide between Grx and the target
`protein, which is resolved by the second active site Cys. The
`monothiol mechanism requires only the N-terminal Cys in the
`active site and is used for reducing mixed disulfides between GSH
`and target proteins. Although the N-terminal Cys is conserved in
`CGFS-type monothiol Grx, they lack oxidoreductase activity
`when tested with standard Grx model substrates (18). Several
`members ofthe monothiol Grxs family, including yeast Grx3 and
`Grx4. were recently shown to fonn [2Fe-2S]~bridged homodimers
`with the CGFS active sites providing two Cys ligands (I9-21).
`interestingly. two glutathione molecules (GSH or y—glutamyl-
`cysteinylglycine) provide the other two cluster ligands. GSH is an
`abundant tripeptide that serves as the primary intracellular thiol
`redox buffer and a cofactor for glutaredoxins and other anti-
`oxidant enzymes (22). in the three published crystal structures of
`[2Fe-2S]-bridged dlthiol and monothiol Grx proteins, the GSH
`molecules are covalently linked to the cluster but held in place by
`noncovalent interactions with theGSH binding pocket in the Grx
`protein (21. 23, 24). GSH seems to play a role in yeast Grx3/4
`function since GSH binding residues in Grx3/4 are essential for
`regulation of Aftl activity (9). Based on previous studies. several
`possible functions for monothiol Grxs in iron metabolism have
`been proposed. Grits may act as scaffolds for Fe-S cluster
`
`Li et al.
`
`Article
`
`Escherichia call‘ as a protein that induces a round cell shape when
`overcxpressed (26). Although BolA-like proteins are found in
`a wide variety of prokaryotes and eukaryotes, their specific
`molecular function is unknown. Genome-wide yeast two-hybrid
`assays have identified a physical interaction between cytosolic
`monothiol Grxs and BolA-like proteins in both S. cerevisiae and
`Drasaphila mclanogaster (27, 28). In addition, proteomewide
`FLAG- and TAP-tag affinity purification studies in yeast and
`E. cali have shown that BolA-like proteins such as Fra2 copurify
`with monothiol Grxs (29-31). The physical interaction between
`yeast Cvrx3/Grx4 and the BolA-like protein Fra2 was recently
`confirmed by immunoprecipitation and split YFP tagging (8).
`Finally, comparative genomic analyses also predict a functional
`interaction between monothiol Grxs and BolA-like proteins
`since they are neighbors in several prokaryotic genomes (25).
`Furthermore. genes encoding the BolA and monothiol Grx
`proteins exhibit strong genome cooccurrence since almost all
`organisms that possess a BolA-like protein also have a CGFS
`monothiol Grx, while organisms that lack a BolA-like protein
`almost always lack a CGFS-type Grx (25, 32). Taken together,
`these data demonstrate a strong phylogenetic connection be-
`tween the two protein families. However,
`the nature of the
`interaction between CGFS-type Grxs and BolA-like proteins
`has not been previously determined,
`This study is aimed at characterizing the interaction between
`yeast Grx3/4 and Fra2 in vitro using biochemical, spectroscopic,
`and analytical techniques. We show here that both Grx3 and
`Grx4 form [2Fe-2S]—containing heterodimers with Fra2 that have
`similar Fe-S coordination environments. However, the UV-vi-
`sible absorption. CD.
`resonance Raman. EPR, ENDOR,
`Mossbauer, and EXAFS spectra of reconstituted [2Fe-2S]-
`bridged Grx3 or Grx4 homodimers are markedly different from
`[2Fe-ZS] Fra2-Grx3/4 heterodimers,
`indicating differences in
`cluster coordination. Furthermore, we have detennined that
`conserved residues required for Grx3 and Grx4 Fe signaling
`in vivo are also required for Fe-S complex formation with Fral
`in virro. This study thus provides new insight into the molecular
`details of intracellular Fe signaling and establishes the ubiquitous
`monothiol Grxs and BolA«like proteins as a novel type of Fe-S
`cluster binding regulatory complex.
`
`EXPERIMENTAL PROCEDURES
`Plasmid Construction. Construction of the yeast Grx3
`E. cali expression vector pET2la-Grx3 was described pre-
`viously (33). The ORF of yeast Grx4 were amplified from
`S. cerevisiae genomic DNA by PCR using the primers shown
`in Supporting Information Table l and cloned into the Ndel and
`EL-URI sites of pET2la (Novagen) to generate pET2la-Grx4.
`E. cult‘ expression vectors for His—tagged Fral (pET2la-Fral-
`His.) and Fra2 (pET2la-Fra2-His6) were kindly provided by
`Jerry Kaplan (University of Utah) (8). The untagged Fra2
`expression vector pET2la~Fra2 was constructed by amplifying
`the Fra2 ORF without the His tag from pET2la-Fra2~His,<, and
`
`(QuikChange kit; Stratagene) using primers listed in Supporting
`Information Table 1. pET2la—Grx3(Al-121) was created by
`introducing an Ndel restriction site at position 122 in pET2la—
`Grx3 by site-directed mutagenesis, digesting the plasmid with
`Ndel to remove the coding sequence for amino acids I-121, and
`religating the plasmid. pET‘2la-Grx3(Al22-250) were created
`by introducing a stop codon and Hindlll site at position 122,
`digesting the plasmid with Hindlll to remove the coding sequence
`for amino acids 122-250, and religating the plasmid. The cDNA
`for human Grx2 (hGrx2) (Open Biosystcms) was PCR amplified
`without the mitochondrial targeting signal (amino acids 41-164)
`and subcloned into pET24cl (Novagcn) using the N001 and
`Ec0Rl restriction sites to make pE'I24d-hGrx2. The sequence
`integrity ofall plasmids was continued by double—stranded DNA
`sequencing (Environmental Genomics Facility. University of
`South Carolina School of Public Health).
`Protein Expression and Purifimtion. Recombinant Grid
`and Grx4 were both purified using the previously published
`protocol for Grid (33). We note that recombinant Grx3 was
`cloned from the second start site (encoding Met36) to the stop
`codon after determining that the first start site (encoding Metl)
`was not utilized in viva (N. Dingra and C. Outten, unpublished
`data). The Grx3 amino acid sequence numbering in this study
`thus starts with the second start site as Metl. Grx3 (or Grx4) was
`coexprcsscd with Fral and Fra2 by transforming pET2la—Grx3
`(or pET2la-Grx4) and pRSFDuet-l—Fral-l-Iisg/Fra2 into the
`E. cali strain BL2l (DE3). Generally, a l L LB culture was grown
`with shaking at 30 °C and induced with 1 mM isopropyl
`fi—1)—thiogalactoside (IPTG) at OD”, 0.6-0.8. The cells were
`collected by centrifugation 18 h after induction and resuspended
`in 50 mM Tris-MES. pH 8.0,
`followed by sonication
`and ccntrifugation to remove the cell debris. The cell—free
`extract was loaded onto a DEAE anion-exchange column (GE
`Healthcare) equilibrated with 50 mM Tris-MES, pH 8.0.
`The protein was eluted with a salt gradient. and the fractions
`containing Grx3 (or Grx4) and Fra2 were pooled and concen-
`trated to 2 mL. A fraction of Fra2 that was not bound to Grx3
`was also present in the DEAE flow-through and further purified
`as described below. (NH4)2SO4 was added to the Fra2-Grx3
`(or Fra2—Grx4) complex to a final concentration of l M, and
`the sample was loaded onto a phenyl-Sepharose column (GE
`Healthcare) equilibrated with 50 mM Tris-MES, pH 8.0,
`100 mM NaCl. and l M (NH..);SO4. The protein was then eluted
`with a decreasing (NH4)2S04 salt gradient, and the fractions
`containing Grx3 (or Grx4) and Fra2 were concentrated and
`loaded onto a HiLoad Superdex 75 gel filtration column (GE
`Healthcare) equilibrated with 50 mM Tris-MES, pH 8.0, and
`150 mM NaCl. The purest fractions ofthe Fra2—Grx3/4 complex
`as judged by SDS-PAGE were collected and concentrated to
`~250 ;4L with the addition of 5% glycerol and stored at -80 °C.
`Purification of Fra2-Grx3/4 was done aerobically: however, the
`procedure was completed in 1 day using degassed buffers to
`minimize loss of the Fe~S cluster.
`57]-"e-labeled samples ofthe Fra2-Grx3 or F1212-Grx4 complex
`
`9571
`Biochemistry, Vol. 48, Na. 40, 2009
`centrifugation l8 l1 after induction. Subsequent purification of
`l7Fe-labeled F1a2-Grx3 or Fra2-Grx4 utilized the same protocol
`described in the previous paragraph.
`For purification of Fra2 without Grx3 or GIX4, BL21(DE3)
`E. coli cells were transformed with pET2la-Fraz. Fra2 expressed
`in this strain resides in inclusion bodies, thus requiring unfolding
`and subsequent refolding to purify. However, uncomplexed Fra2
`could be purified from the DEAE column l'low—through from
`cells coexpressing Grx3 and F1112 as mentioned above. The Fraz-
`containing DEAE flow—through fractions were adjusted to pH
`6.0 and loaded onto an SP FF cation-exchange column
`(GE Healthcare) equilibrated with 50 mM MES—Na, pH 6.0.
`Fra2 was eluted with a salt gradient, concentrated, and loaded
`onto a HiLoad Superdex 75 gel
`filtration column (GE
`Healthcare) equilibrated with 50 mM Tris-MES, pH 8.0. and
`ISO mM NaCl. The purest fractions of Fraz were collected.
`concentrated to ~500 )rL with the addition of 5% glycerol, and
`stored at -80 °C. The yield of uncomplexed Fra2 from the
`DEAE flow-through was highest when Fraz was coexpressed
`with Grx3(Cl76S) (see Results).
`Recombinant hGrx2 was overexpressed in the E. calf BL2l-
`(DE3) strain and grown at 37 °C with shaking until ODW, = 0,6.
`The cultures were cooled to 20 °C, and 1 mM IPTG was added to
`induce hGrx2 expression. After overnight growth (~18 h) at
`room temperature, cells were harvested by centrifugation and
`stored at -80 °C. The cell pellet was subjected to three freeze-
`thaw cycles, and soluble protein was extracted with 50 mM Tris»
`lICl,
`131'] 8.0. The protein was precipitated with 25-60%
`(Nl—I4);SO4 and the pellet resuspended in 50 mM Tris-I'lCl, plrl
`8.0, and subsequently loaded on a desalting column followed by a
`DEAE column (GE Healthcare) both equilibrated with 50 mM
`Tris-HCL pH 8.0. The majority of hGrx2 did not bind to the
`DEAE column and was collected in the flow—through. These
`fractions were concentrated and loaded onto a HiLoad Superdex
`75 gel filtration column (GE Healthcare) equilibrated with
`50 mM Tris-l-ICl. pH 8.0, and 150 mM NaCl. [2Fe-2S] hGrx2
`elutes as a dimer, while apo hGrx2 elutes as a monomer as
`previously reported (34).
`In Vitro Fe-S Cluster Rez‘or1.r2‘1'ruf1'ar1 an A110 GrX3 and
`Grx4. Reeonstitution of an Fe-S cluster on ape Grx3, 1 mM in
`I00 mM Tris-HCl buffer at pH 7.8, was carried under anaerobic
`conditions (0; < 5 ppm) in a glovebox (Vacuum Atmospheres,
`Hawthorne, CA). The reaction mixture involved 2 mM GSH, a
`16-fold excess of ferrous ammonium sulfate (57Fe—labeled for
`Miissbauer samples) and L»cysteine, and catalytic amounts of
`Azotobacter vinelandii NifS (6.27,uM) and was incubated at room
`temperature for 50 min. Reagents in excess were removed
`anaerobically by loading onto a High-Trap Q-Scpharosc column
`(GE Healthcare) inside the glovebox. Elution was achieved using
`a NaCl gradient with cluster-bound Grx3 eluting between 0.60
`and 0.70 M NaCl. Samples were pooled together as a single
`fraction before concentrating and desalting using Amicon ultra-
`filtration with a YMl0 membrane. The same protocol was
`followed for reconstituting an Fe-S cluster on apt) Grx4.
`
`

`
`9572 Biochemistry. Vol. 48, N0. 40. 2009
`
`5,5'-dithiobis(2-nitrobcnzoic acid)-GSSG reductase cycling
`assay as previously described (38).
`Analytical and Spectroscopic Methods. Analytical gel
`filtration analyses were performed on a Superdex 75 10/300
`GL column (GE Healthcare) equilibrated with 50 mM
`Tris-MES, pH 8.0. and 150 mM NaCl and calibrated with
`the low molecular weight
`gel
`filtration calibration kit
`(GE Healthcare). The buffer was bubbled with N2 overnight
`and degassed to minimize dissolved 02 levels. Elution profiles
`were recorded at 280 nm with a flow rate of 0.5 mL/min.
`UV-visible absorption spectra were recorded using a Beckman
`DU-800 or Shimadzu UV-310] spectrophotometer, and CD
`spectra were recorded on identical samples using a lasco J-715
`spectropolarimeter. Mass spectrometry analysis of purified pro-
`teins was determined using a Bruker UltraFlex MALDI~TOF/
`TOF mass spectrometer. A saturated solution ofsinapinic acid in
`50% acetonitrile and 0. l% nifluoroacetic acid was used as the
`matrix, and myoglobin and ubiquitin were the calibration
`standards. Resonancx: Raman spectra were recorded as pre-
`viously described (39), using an Instruments SA Ramanor
`Ul00O spectrometer coupled with a Coherent Sabre argon ion
`laser, with 20;¢L frozen droplets of l.5~2.6 rnM sample mounted
`on the cold finger of an Air Products Displex Model CSA-202E
`closed cycle refrigerator. X-band (--9.6 GI-I2) EPR spectra were
`recorded using a ESP-300D spectrometer (Bruker, Billerica,
`MA). muipped with an ESR 900 helium flow cryostat (Oxford
`Instruments, Concord. MA). and quantified under nonsaturating
`conditions by double integration against a 1.0 mM CuEDTA
`standard. Q-band (~35 GHz) CW ENDOR experiments were
`carried out at 2 K using a spectrometer described previously (40).
`Mossbauer spectra were recorded by using the previously de-
`scribed instrumentation (41). The zero velocity of the spectra
`refers to the centroid of a room temperature spectrum of a
`metallic Fe foil. Analysis of the Mdssbauer data was performed
`with the WMOSS program (SEE Co.).
`X-ray absorption spectra were measured at
`the National
`Synchrotron Light Source (NSLS) beamline X3-B and at Stan-
`ford Synchrotron Radiation Laboratory (SSRL) beamlines 9-3
`and 7-3. Concentrated samples of the Fraz-Grx3/4 heterodimer
`were mixed with glycerol (final concentration 30% v/v glycerol
`and 1—2 mM Fe) and were frozen in a Lucite sample cell covered
`with Kapton tape. Spectra were collected at cryogenic tempera-
`tures using a helium displex cryostat at NSLS (30 K) or with an
`Oxford Instruments continuous flow liquid helium crysostat at
`SSRL (10 K). Beamlines were equipped with double crystal
`monochrornators with Si[l ll] (NSLS) or Si[220] (SSRL) crystals.
`Hannonic rejection mirrors were used. and spectra were collected
`under fully tuned conditions. Canberra solid-state germanium
`detectors (l3 element (NSLS) or 30 element (SSRL)) were used to
`detect the iron Kot fluorescence. Data points were collected every
`5 eV in the proedge region. every 0.25 eV in the edge region.
`and every 005 k in the EXAFS region. Scans were typically
`collected for 45 min, with data acquisition time increasing to 5 s
`
`Li et al.
`
`scans were initiated at fresh locations of the sample surface. At
`this size. six fresh sample spots were monitored per sample.
`Replicate samples were measured with equivalent results.
`Data were processed using the Mac OS 10 version of EX-
`AFSPAK, a suite of data analysis programs available on the
`SSRL Web site. This program was interfaced to Fel‘l‘7.2 to
`generate the theoretical scattering models used in the fits. The
`value of A539 was fixed to a value of -10 eV and the scale factor
`was fixed at 0.9, values that yield the correct crystallographically
`determined bond lengths and coordination numbers for iron
`model complexes Bond length. R. and the Debye-Waller factor
`(oz) were varied freely in each fit. Coordination numbers were
`incremented in fractional steps to refine the optimal number
`based on goodness oftit. Fit quality wasjudged using a modified
`F value, F’, that adjusts for the number ofvariables used in a fit.
`All fits reported here are to unfiltered data over a k range of 1-14
`A". Both single scattering and multiple scattering models were
`used to lit the data. In the latter, parameters for an imidazole ring
`scatterer were used to model histidine ligands. For these fits, the
`Fe-N;,.,;,, distance and o2 values were floating freely. and the
`other atoms in the imidazole ring were linked to the refined value
`F€“Namia-
`
`RESULTS
`
`Fra2 and Grx3/4 Copurify as a Heterodimeric Complex.
`To characterize the interactions between Fra2, Grx3, and Grx4,
`the individual proteins were initially expressed and purified
`separately for in vitro analysis. Soluble recombinant Grx3 and
`Grx4 were easily extracted from E. coli yielding the apo,
`monomeric
`forms upon aerobic purification (Figure
`1,
`Table 1). However. recombinant Fraz was largely found in
`inclusion bodies and partially degraded upon purification
`(Figure l). The molecular mass of the purified proteins (with
`the first Met removed in each case) was confirmed by MALDI-
`TOF mass spectrometry (Table 1). Since Fra2 interacts with Fral
`and Grx3/4 in vivo (8), we tested whether cocxprcssion of the
`interacting proteins improved the solubility of Fra2. Fral, Fra2,
`and Grid were cocxpressed using an E. coli strain cotrans-
`formed with one plasmid expressing Fral and H32 and another
`expressing Grx3. After collecting the induced cells. we immedi-
`ately noted that the cell pellet was a reddish brown color that was
`not observed when the proteins were expressed separately.
`SDS~PAGE analysis showed that Fraz and Grid were both
`expressed at high levels, while the Fral protein was not visibly
`detectable(cxpccted mass = 86.0 kDa with His tag) (Figure 1A).
`Furthermore. Fra2 and Grid were found to copurify as a reddish
`brown-colored complex with a higher apparent molecular mass
`than the individual proteins as determined by analytical gel
`filtration (Figure 1B. Table 1). Similar results were obtained
`upon coexpression of Fra2 with Grx4. The reddish brown Fra2-
`Grx complex was also purified upon expression of Fra2-Grx3
`or Fra2-Grx4 without Fral.
`indicating that Fral was not
`
`Grxii
`+Fra2
`GIX3
`Ft'a2
`3‘ldNllPNlIPNl|P
`
`Biochemistry, Vol. 48, No. 40, 2009
`
`9573
`
`-Fa-S
`-—-Fe-S
`
`619:3
`Fro2
`«G06
`
`6
`
`10
`
`12
`volume (mL)
`
`14
`
`15
`
`FIGURE l: Fra2 and Grx3/4 copurify as a complex. (A) SDS—PAGE
`analysis of purified Fra2 and Grx3. Fra2 and Grx3 wereindividually
`expressed or coexpressed. NI = noninduced cells, I = induced cells,
`and P = purified protein. The 12- 13 kDa band below Fra2 in the
`purified Fra2 and Grx3-Fra2 lanes is a degradation product of Fru2.
`The bands shown with an asterisk in the last lane were identified
`by MALDI-TOF as the E. mli translational elongation factors
`TufA (43.4 kDa) and FusA (77.6 kDa). (B) Gel filtration chromato-
`grams of apo (upper chrornatogram) and Fe-S forms (bottom
`chromntogram) of Fral and Grx3 (0.5 ,ug loaded).
`
`Table 1: Molecular Mass Analysis of Fraz. Grid. and Grx4 Complexes“
`theoretical
`sample
`gel filtration
`MALDI
`
`13971 (monomer)
`13971. l2824"
`19500
`apo Fraz
`28130 (monomer)
`28120
`37000
`npo Grx]
`27493 (monomer)
`27492
`37200
`apo Grx4
`42101 (heterodimer)
`ND"
`52600
`[2Fe-ZS] Grx}-Fra2
`41464 (heterodirner)
`ND
`52300
`[2Fe-ZS] Grx4-FmZ
`56260 (homodimer)
`ND
`71500
`[2F=~2S] Grx3
`54968 (homodimer)
`ND
`65700
`[2Fc-2S] Grx4
`“All masses are shown in Da. "This second peak is attributed to the Fr-a2
`proteolytie fragment shown in Figure 1A. ‘ND, not determined.
`
`Grx3/4 does not involve a covalent,
`bond.
`Fra2-Grx3/4 Birtdsa [2Fe-25]‘, ‘L Cluster. The UV—visible
`absorption spectra of both Fra2-Grx complexes are nearly
`
`intermolecular disulfide
`
`500 600 700
`300 400
`Wavelength (nm)
`
`800
`
`FIGURE 2: UV—visible absorption spectra of as-purified forms of
`Fe-5 cluster-bound Fral-Grx3 (black line) and Fraz-Grx4 (gray
`line). c values are based on Fra2—Grx heterodimer concentrations.
`
`Table 2: Fe. 52’. and GSH Measurements in Purified Fe-S Proteins”
`sample
`Fe
`52'
`GSH
`Fe:S:GSH
`1.7:l:0.2
`0.8:l:0.l
`l:l:0.5
`[2Fe-2S] Fraz-Grx}
`1.7 i 0.2
`1.3 :l: 0.1
`0.6 i0.l
`1
`9:0.4
`[2Fc-2S] Fru2—Grx4
`1.4 :l: 0.1
`[ZI-‘e-2S] hGrx2
`l.9:l:0.l
`2.0i0.l
`1.510.]
`l:l:0.8
`‘Molar values are reported per dimer. Data are the average of three
`independent samples.
`
`and ~0.7 [2Fe~2S]“ clusters per Fra2-Grx4 heterodimer in
`aerobically purified samples. Based on the analytical data and
`the Mossbauer data for [2Fc-2S] Fra2-Grx3. which indicate that
`97% of the Fe is in the form of [2Fc-2S]2+ clusters (see below).
`the UV—visible absorption data indicate on extinction coefficicnl
`at 393 nm = 8.3 :: 1.0 mM"‘ cm" on a per cluster busis for the
`[2Fe-2S]“ center in the Fra2-Grx3/4heterodimer. which is at the
`middle of the range reported for the dominant hand in the
`390-430 nm region from [2Fe-2S]2 ‘ clusters (42). As mentioned
`above, monothio Grxs have been shown to form [2Fc-2S]-
`bridged homodimers (19-21); however. a [2Fe-ZS]-bridged het-
`crodimer involving Grx and another protein has not previously
`been reported.
`To test whether Fe-S binding is required for the Fra2-Grx}f4
`interaction in vitro,
`the purified Fra2-Grx3 hctcrodimer was
`treated with a 20-fold excess of EDTA and DTT anaerobically
`for l h at 4 °C and then loaded onto an analytical gel filtration
`column. The proteins lost
`the reddish brown color but still
`coeluted as a heterodimeric complex. Measurement of Fe and
`acid-labile sulfide in the eluted apo heterodimer confirmed loss of
`the cluster (:03 Fe/heterodimer, 50.5 S2‘/heterodimer), sug-
`gesting that the Fra2-Grx3 interaction is not absolutely metal-
`dependent. This result is consistent with in viva coimmunopreci—
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket